These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26481959)

  • 21. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thirty-Day Readmissions After Left Ventricular Assist Device Implantation in the United States: Insights From the Nationwide Readmissions Database.
    Agrawal S; Garg L; Shah M; Agarwal M; Patel B; Singh A; Garg A; Jorde UP; Kapur NK
    Circ Heart Fail; 2018 Mar; 11(3):e004628. PubMed ID: 29519902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Readmissions after continuous flow left ventricular assist device implantation.
    Kimura M; Nawata K; Kinoshita O; Yamauchi H; Hoshino Y; Hatano M; Amiya E; Kashiwa K; Endo M; Kagami Y; Nemoto M; Ono M
    J Artif Organs; 2017 Dec; 20(4):311-317. PubMed ID: 28752193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced Anxiety and Depression in Patients With Advanced Heart Failure After Left Ventricular Assist Device Implantation.
    Yost G; Bhat G; Mahoney E; Tatooles A
    Psychosomatics; 2017; 58(4):406-414. PubMed ID: 28408037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Readmissions after implantation of axial flow left ventricular assist device.
    Hasin T; Marmor Y; Kremers W; Topilsky Y; Severson CJ; Schirger JA; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Stulak JM; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2013 Jan; 61(2):153-63. PubMed ID: 23219299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual Concerns of Patients With Implantable Left Ventricular Assist Devices.
    Merle P; Maxhera B; Albert A; Ortmann P; Günter M; Lichtenberg A; Saeed D
    Artif Organs; 2015 Aug; 39(8):664-9. PubMed ID: 26148127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.
    Imamura T; Jeevanandam V; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Rodgers D; Besser S; Chung B; Nguyen A; Narang N; Ota T; Song T; Juricek C; Mehra M; Costanzo MR; Jorde UP; Burkhoff D; Sayer G; Uriel N
    Circ Heart Fail; 2019 Feb; 12(2):e005094. PubMed ID: 30704291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function with left ventricular assist devices: the poorer the preoperative renal function, the longer the recovery.
    Ma L; Fujino Y; Matsumiya G; Sawa Y; Mashimo T
    Med Sci Monit; 2008 Dec; 14(12):CR621-7. PubMed ID: 19043370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
    Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN
    Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does elective or emergent operative status influence outcomes in patients undergoing implantation of left ventricular assist devices?
    Tsiouris A; Morgan JA; Nemeh HW; Hodari A; Shah R; Brewer RJ; Paone G
    Heart Surg Forum; 2014 Apr; 17(2):E64-72. PubMed ID: 24808443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discharge outcomes in patients with paracorporeal biventricular assist devices.
    Thomas SS; Smallwood J; Smith CM; Griffin LM; Shekar P; Chen FY; Couper GS; Givertz MM
    Ann Thorac Surg; 2014 Mar; 97(3):894-900. PubMed ID: 24280185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
    Warraich HJ; Allen LA; Blue LJ; Chaussee EL; Thompson JS; McIlvennan CK; Flint KM; Matlock DD; Patel CB
    Am Heart J; 2019 Jul; 213():91-96. PubMed ID: 31129442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricuspid Valve Annular Dilation as a Predictor of Right Ventricular Failure After Implantation of a Left Ventricular Assist Device.
    Goldraich L; Kawajiri H; Foroutan F; Braga J; Billia P; Misurka J; Stansfield WE; Yau T; Ross HJ; Rao V
    J Card Surg; 2016 Feb; 31(2):110-6. PubMed ID: 26748904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.